glp 1 gip agonist gip/glp-1 agonists TrimRX New strategies for the treatment

The researchers of that study called for urgent clarification of drug- and patient-related risk factors, an understanding that has become more important as GLP-1 receptor agonist use continues to rise across the United States, especially for weight management

Soon after developing GLP-1s, researchers uncovered a second therapeutic effect that could benefit an even larger patient population: sustainable, clinically meaningful weight loss

Some foreign scholars compared the number of pancreatic cancer patients treated with exenatide and those treated with other hypoglycemic drugs, and the results revealed that the number of pancreatic cancer patients treated with exenatide was 2.9 times greater than that of patients treated with other hypoglycemic drugs (82)

Cell Commun

David Rind, a primary care physician and the chief medical officer for the Institute for Clinical and Economic Review, a group that determines fair prices for drugs

What are the key renal benefits of combining SGLT2is with GLP1-RAs compared to using each therapy alone in individuals with T2D